My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 7

    1.

    Acquired mutations in TET2 are common in myelodysplastic syndromes.

    Langemeijer SM, Kuiper RP, Berends M, Knops R, Aslanyan MG, Massop M, Stevens-Linders E, van Hoogen P, van Kessel AG, Raymakers RA, Kamping EJ, Verhoef GE, Verburgh E, Hagemeijer A, Vandenberghe P, de Witte T, van der Reijden BA, Jansen JH.

    Nat Genet. 2009 Jul;41(7):838-42. Epub 2009 May 31.PMID: 19483684 [PubMed - indexed for MEDLINE]Related articles

    2.

    Mutation in TET2 in myeloid cancers.

    Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Massé A, Kosmider O, Le Couedic JP, Robert F, Alberdi A, Lécluse Y, Plo I, Dreyfus FJ, Marzac C, Casadevall N, Lacombe C, Romana SP, Dessen P, Soulier J, Viguié F, Fontenay M, Vainchenker W, Bernard OA.

    N Engl J Med. 2009 May 28;360(22):2289-301.PMID: 19474426 [PubMed - indexed for MEDLINE]Related articles

    3.

    Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.

    Jankowska AM, Szpurka H, Tiu RV, Makishima H, Afable M, Huh J, O'Keefe CL, Ganetzky R, McDevitt MA, Maciejewski JP.

    Blood. 2009 Jun 18;113(25):6403-10. Epub 2009 Apr 16.PMID: 19372255 [PubMed - indexed for MEDLINE]Related articles

    4.

    Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML.

    Tefferi A, Lim KH, Abdel-Wahab O, Lasho TL, Patel J, Patnaik MM, Hanson CA, Pardanani A, Gilliland DG, Levine RL.

    Leukemia. 2009 Jul;23(7):1343-5. Epub 2009 Mar 19. No abstract available. PMID: 19295549 [PubMed - indexed for MEDLINE]Related articles

    5.

    TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis.

    Tefferi A, Pardanani A, Lim KH, Abdel-Wahab O, Lasho TL, Patel J, Gangat N, Finke CM, Schwager S, Mullally A, Li CY, Hanson CA, Mesa R, Bernard O, Delhommeau F, Vainchenker W, Gilliland DG, Levine RL.

    Leukemia. 2009 May;23(5):905-11. Epub 2009 Mar 5.PMID: 19262601 [PubMed - indexed for MEDLINE]Related articles

    6.

    Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates.

    Tefferi A, Levine RL, Lim KH, Abdel-Wahab O, Lasho TL, Patel J, Finke CM, Mullally A, Li CY, Pardanani A, Gilliland DG.

    Leukemia. 2009 May;23(5):900-4. Epub 2009 Mar 5.PMID: 19262599 [PubMed - indexed for MEDLINE]Related articles

    7.

    Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.

    Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M, Malinge S, Yao J, Kilpivaara O, Bhat R, Huberman K, Thomas S, Dolgalev I, Heguy A, Paietta E, Le Beau MM, Beran M, Tallman MS, Ebert BL, Kantarjian HM, Stone RM, Gilliland DG, Crispino JD, Levine RL.

    Blood. 2009 Jul 2;114(1):144-7. Epub 2009 May 6.PMID: 19420352 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity